Hopeful of Covid-19 vaccine by year end: ICMR chief Balram Bhargava

‘’Whoever develops the vaccine first, India or China will have to scale it up,’’ says ICMR Director General Balram Bhargava
After the August 15 deadline set by Balram Bhargava, director general of Indian Council of Medical Research (ICMR), for a Covid-19 vaccine turned controversial, the man at the centre of it all is looking at more realistic targets. Bhargava, during an interview, says he is hopeful of a vaccine by the end of this year or early next year.

 

Hitting out at his critics for the ambitious deadline, he’s emphatic that it is the country’s moral duty to fast-track the vaccine without compromising on science and ethics. Optimistic on plasma therapy research and indigenous candidate vaccines, he calls India the pharmacy of the world. ‘’Whoever develops the vaccine first, India or China will have to scale it up,’’ Bhargava points out.   

 

“As we are keen to get a breakthrough as soon as possible, this doesn't mean that best of India’s medical professionals and research scientists should be second-guessed for their professionalism or adherence to the highest scientific rigour,’’ the ICMR chief says.

 



Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel